Tirzepatide (Mounjaro) launched in India in March 2025, promising new hope for diabetes and obesity treatment. An expert ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

However, even with its relatively lower price compared to the US, the question remains — can she truly afford it? And if she ...

The India launch of Eli Lilly's popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its ...

Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, ...

“We’ve been on this journey for a while," said 'Spy Kids' actor Daryl Sabara Weiss Eubanks/NBCUniversal via Getty Meghan Trainor has been taking Mounjaro for weight loss alongside her ...

Lilly, which already markets the diabetes drug Mounjaro and the weight-loss treatment ... by 1.3% to 1.6% across three doses (3 mg, 12 mg, and 36 mg). Three doses are being tested - 3 mg, 12 ...

HYDERABAD (Reuters) -The India launch of Eli Lilly's popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its availability, with some Indian doctors fielding ...